Michael Borre

15.6k citations

270 papers · 8.1k indexed · h-index 48

Impact in

Cancer Research top 0.5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Cancer, Lipids, and Metabolism
Pulmonary and Respiratory Medicine top 0.5%
- Prostate Cancer Treatment and Research
- Prostate Cancer Diagnosis and Treatment

Papers in ⓘ

Pulmonary and Respiratory Medicine 166
- Prostate Cancer Treatment and Research 124
- Prostate Cancer Diagnosis and Treatment 82
Molecular Biology 76
- Epigenetics and DNA Methylation 28

Co-authors: Torben F. Ørntoft (51 shared papers)Lars Dyrskjøt (40 shared papers)Karina D. Sørensen (64 shared papers)S. Høyer (46 shared papers)Jens Overgaard (17 shared papers)B Nerstrøm (11 shared papers)Mary Nguyen-Nielsen (8 shared papers)Jørgen Bjerggaard Jensen (24 shared papers)
Journals: International Journal of Cancer (11 papers)Journal of Clinical Oncology (11 papers)British Journal of Urology (11 papers)British Journal of Cancer (10 papers)Cancer Research (9 papers)
Partner nations: Denmark United States United Kingdom

In The Last Decade

Michael Borre

265 papers receiving 8.0k citations

Peers

Countries citing papers authored by Michael Borre

Since Specialization

Citations

This map shows the geographic impact of Michael Borre's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Borre with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Borre more than expected).

Fields of papers citing papers by Michael Borre

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Borre. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Borre. The network helps show where Michael Borre may publish in the future.

Co-authors

The 25 scholars most cited alongside Michael Borre, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michael Borre Line = papers co-authored together Michael Borre links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 270 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Coordinated epigenetic repression of the miR‐200 family and miR‐205 in invasive bladder cancer International Journal of Cancer ·Erik D. Wiklund, Jesper B. Bramsen, Toby Hulf, Lars Dyrskjøt, Ramshanker Ramanathan, Thomas B. Hansen, Sune B. Villadsen, Shan Gao, Marie S. Ostenfeld, Michael Borre, Marcus E. Peter, Torben F. Ørntoft, Jørgen Kjems, Susan J. Clark	2010	317
2	Genomic Profiling of MicroRNAs in Bladder Cancer: miR-129 Is Associated with Poor Outcome and Promotes Cell Death In vitro Cancer Research ·Lars Dyrskjøt, Marie S. Ostenfeld, Jesper B. Bramsen, Asli Silahtaroglu, Philippe Lamy, Ramshanker Ramanathan, Niels Fristrup, Jens Ledet Jensen, Claus L. Andersen, Karsten Zieger, Sakari Kauppinen, Benedicte Parm Ulhøi, Jørgen Kjems, Michael Borre, Torben F. Ørntoft	2009	315
3	Intrinsic markers of tumour hypoxia and angiogenesis in localised prostate cancer and outcome of radical treatment: a retrospective analysis of two randomised radiotherapy trials and one surgical cohort study The Lancet Oncology ·Roy Vergis, Catherine M. Corbishley, A. Norman, Jaclyn Bartlett, Sameer Jhavar, Michael Borre, Sara Heebøll, Alan Horwich, Robert Huddart, Vincent Khoo, Rosalind A. Eeles, Colin Cooper, Matthew R. Sydes, David P. Dearnaley, Chris Parker	2008	229
4	Microvessel density predicts survival in prostate cancer patients subjected to watchful waiting British Journal of Cancer ·Michael Borre, B.V. Offersen, B Nerstrøm, Jens Overgaard	1998	194
5	Phase III Trial of PROSTVAC in Asymptomatic or Minimally Symptomatic Metastatic Castration-Resistant Prostate Cancer Journal of Clinical Oncology ·James L. Gulley, Michael Borre, Nicholas J. Vogelzang, Siobhan Ng, Neeraj Agarwal, Chris Parker, David Pook, Per Rathenborg, Thomas W. Flaig, Joan Carles, Fred Saad, Neal D. Shore, Liddy Chen, Christopher R. Heery, Winald R. Gerritsen, Frank Priou, Niels Christian Langkilde, A I Novikov, Philip W. Kantoff	2019	183
6	Alternative Splicing in Colon, Bladder, and Prostate Cancer Identified by Exon Array Analysis Molecular & Cellular Proteomics ·Kasper Thorsen, Karina D. Sørensen, Anne Sofie Brems-Eskildsen, Charlotte Modin, Mette Gaustadnes, Anne-Mette K. Hein, Mogens Kruhøffer, Søren Laurberg, Michael Borre, Kai Wang, Søren Brunak, Adrian R. Krainer, Niels Tørring, Lars Dyrskjøt, Claus L. Andersen, Torben F. Ørntoft	2008	181
7	Comprehensive Genome Methylation Analysis in Bladder Cancer: Identification and Validation of Novel Methylated Genes and Application of These as Urinary Tumor Markers Clinical Cancer Research ·Thomas Reinert, Charlotte Modin, Francisco M. Castano, Philippe Lamy, Tomasz K. Wojdacz, Lise Lotte Hansen, Carsten Wiuf, Michael Borre, Lars Dyrskjøt, Torben F. Ørntoft	2011	169
8	Genomic Alterations in Liquid Biopsies from Patients with Bladder Cancer European Urology ·Karin Birkenkamp‐Demtröder, Iver Nordentoft, Emil Christensen, S. Høyer, Thomas Reinert, Søren Vang, Michael Borre, Mads Agerbæk, Jørgen Bjerggaard Jensen, Torben F. Ørntoft, Lars Dyrskjøt	2016	168
9	Diagnostic and Therapeutic Strategies for Prostate Cancer Seminars in Nuclear Medicine ·Mary Nguyen-Nielsen, Michael Borre	2016	148
10	Safety and Efficacy of the Specific Endothelin-A Receptor Antagonist ZD4054 in Patients with Hormone-Resistant Prostate Cancer and Bone Metastases Who Were Pain Free or Mildly Symptomatic: A Double-Blind, Placebo-Controlled, Randomised, Phase 2 Trial European Urology ·Nicholas D. James, Armelle Caty, Michael Borre, Bernard A. Zonnenberg, Philippe Beuzeboc, Thomas Morris, De Phung, Nancy A. Dawson	2008	137
11	miR-145 induces caspase-dependent and -independent cell death in urothelial cancer cell lines with targeting of an expression signature present in Ta bladder tumors Oncogene ·Marie S. Ostenfeld, Jesper B. Bramsen, Philippe Lamy, Sune B. Villadsen, Niels Fristrup, Karina D. Sørensen, Benedicte P. Ulhøi, Michael Borre, Jørgen Kjems, Lars Dyrskjøt, Torben F. Ørntoft	2009	125
12	Androgen-deprivation Therapy in Treatment of Prostate Cancer and Risk of Myocardial Infarction and Stroke: A Nationwide Danish Population-based Cohort Study European Urology ·Christina Gade Jespersen, Mette Nørgaard, Michael Borre	2013	111
13	Efficacy of a multiprofessional rehabilitation programme in radical cystectomy pathways: A prospective randomized controlled trial Scandinavian Journal of Urology ·Bente Thoft Jensen, Annemette Krintel Petersen, Jørgen Bjerggaard Jensen, Sussie Laustsen, Michael Borre	2014	111
14	Expression profiling of prostate cancer tissue delineates genes associated with recurrence after prostatectomy Scientific Reports ·Martin M. Mortensen, S. Høyer, Anne-Sophie Lynnerup, Torben F. Ørntoft, Karina D. Sørensen, Michael Borre, Lars Dyrskjøt	2015	110
15	Mutational Context and Diverse Clonal Development in Early and Late Bladder Cancer Cell Reports ·Iver Nordentoft, Philippe Lamy, Karin Birkenkamp‐Demtröder, Karey Shumansky, Søren Vang, Henrik Hornshøj, Malene Juul, Palle Villesen, Jakob Hedegaard, Andrew Roth, Kasper Thorsen, S. Høyer, Michael Borre, Thomas Reinert, Niels Fristrup, Lars Dyrskjøt, Sohrab P. Shah, Jakob Skou Pedersen, Torben Ørntoft	2014	110
16	DNA Methylation Signatures for Prediction of Biochemical Recurrence After Radical Prostatectomy of Clinically Localized Prostate Cancer Journal of Clinical Oncology ·Christa Haldrup, Kamilla Mundbjerg, Else Marie Vestergaard, Philippe Lamy, Peter J. Wild, Wolfgang A. Schulz, Christian Arsov, Tapio Visakorpi, Michael Borre, S. Høyer, Torben F. Ørntoft, Karina D. Sørensen	2013	108
17	Association between immunohistochemical expression of vascular endothelial growth factor (VEGF), VEGF-expressing neuroendocrine-differentiated tumor cells, and outcome in prostate cancer patients subjected to watchful waiting. PubMed ·Michael Borre, B Nerstrøm, J Overgaard	2000	108
18	Abiraterone Alone or in Combination With Enzalutamide in Metastatic Castration-Resistant Prostate Cancer With Rising Prostate-Specific Antigen During Enzalutamide Treatment Journal of Clinical Oncology ·Gerhardt Attard, Michael Borre, Howard Gurney, Yohann Loriot, Corina Andresen-Daniil, Ranjith Kalleda, Trinh Pham, Mary-Ellen Taplin, (unknown)	2018	108
19	The miR-143/-145 cluster regulates plasminogen activator inhibitor-1 in bladder cancer British Journal of Cancer ·Sune B. Villadsen, Jesper B. Bramsen, Marie S. Ostenfeld, Erik D. Wiklund, Niels Fristrup, Shan Gao, Thomas B. Hansen, Trine I. Jensen, Michael Borre, Torben F. Ørntoft, Lars Dyrskjøt, Jørgen Kjems	2011	100
20	Tumor‐promoting macrophages induce the expression of the macrophage‐specific receptor CD163 in malignant cells International Journal of Cancer ·Maciej Bogdan Maniecki, Anders Etzerodt, Benedicte Parm Ulhøi, Torben Steiniche, Michael Borre, Lars Dyrskjøt, Torben F. Ørntoft, Søren K. Moestrup, Holger Jon Møller	2012	97

About Michael Borre

Michael Borre is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology, Cancer Research, Oncology and Surgery, having authored 270 papers that have together received 8.1k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (124 papers), Prostate Cancer Diagnosis and Treatment (82 papers), Bladder and Urothelial Cancer Treatments (42 papers), Cancer, Lipids, and Metabolism (40 papers), Epigenetics and DNA Methylation (28 papers), Cancer-related molecular mechanisms research (19 papers), MicroRNA in disease regulation (14 papers) and Colorectal Cancer Screening and Detection (13 papers). The work is most often cited by research in Cancer Research (2.9k citations), Pulmonary and Respiratory Medicine (3.3k citations), Oncology (1.8k citations), Molecular Biology (3.6k citations) and Urology (310 citations). Michael Borre has collaborated with scholars based in Denmark, United States and United Kingdom. Frequent co-authors include Torben F. Ørntoft, Lars Dyrskjøt, Karina D. Sørensen, S. Høyer, Jens Overgaard, B Nerstrøm, Mary Nguyen-Nielsen, Jørgen Bjerggaard Jensen, Benedicte Parm Ulhøi and Mette Nørgaard. Their work appears in journals such as International Journal of Cancer, Journal of Clinical Oncology, British Journal of Urology, British Journal of Cancer and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact